IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

PTC Therapeutics Inc

CUSIP: 69366JAA9 | 3 institutional holders

Quarters

Q2 2016Q1 2016Q4 2015Q3 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2016

Ameriprise Financial Inc13,900,000
0.0% of portfolio›$6.5K
Advent Capital Management10,998,000
0.1% of portfolio›$5.2K
StyleTurnoverLocationFiled
Ameriprise Financial Inc
13,900,000$6.5K0.0%CoreMediumMinneapolis, MN2016-08-08
Advent Capital Management
10,998,000$5.2K0.1%Deep ValueMediumNew York, NY2016-08-05